Brief: Exscientia Announces Expansion Of Its Precision Oncology Pipeline
14/03/2023 11:21
March 14 (Reuters) - Exscientia PLC EXAI.O :
* EXSCIENTIA ANNOUNCES EXPANSION OF ITS PRECISION ONCOLOGY
PIPELINE
* EXSCIENTIA PLC - PRECISION DESIGNED LSD1 AND MALT1
INHIBITORS
CURRENTLY PROGRESSING THROUGH IND-ENABLING STUDIES
* EXSCIENTIA PLC - COMPANY ON TRACK TO MEET TARGET OF FOUR
MOLECULES IN CLINICAL DEVELOPMENT BY 2024
Source text for Eikon: ID:nBw1L6wQ7a
Further company coverage: EXAI.O
Recent news on Exscientia
See all newsExscientia PLC expected to post a loss of 9 cents a share - Earnings Preview
Brief: Exscientia Achieves Milestones For Two Programmes In Sanofi Collaboration
Exscientia PLC reports results for the quarter ended in June - Earnings Summary
Deals of the day-Mergers and acquisitions
Biotech firm Recursion to buy smaller peer Exscientia for $688 million